Treatment outcome of patients with advanced stage natural killer/T-cell lymphoma: elucidating the effects of asparaginase and postchemotherapeutic radiotherapy
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Treatment outcome of patients with advanced stage natural killer/T-cell lymphoma: elucidating the effects of asparaginase and postchemotherapeutic radiotherapy
Authors
Keywords
Extranodal natural killer/T-cell lymphoma, Asparaginase, Radiotherapy, Prognosis
Journal
ANNALS OF HEMATOLOGY
Volume 94, Issue 7, Pages 1175-1184
Publisher
Springer Nature
Online
2015-02-17
DOI
10.1007/s00277-015-2336-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Concurrent chemoradiotherapy followed by l-asparaginase-containing chemotherapy, VIDL, for localized nasal extranodal NK/T cell lymphoma: CISL08-01 phase II study
- (2014) Seok Jin Kim et al. ANNALS OF HEMATOLOGY
- Combination of gemcitabine, l-asparaginase, and oxaliplatin (GELOX) is superior to EPOCH or CHOP in the treatment of patients with stage IE/IIE extranodal natural killer/T cell lymphoma: a retrospective study in a cohort of 227 patients with long-term follow-up
- (2014) Wang Liang et al. MEDICAL ONCOLOGY
- Combined therapy in untreated patients improves outcome in Nasal NK/T lymphoma: results of a clinical trial
- (2013) Agustin Avilés et al. MEDICAL ONCOLOGY
- SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group
- (2012) Y.-L. Kwong et al. BLOOD
- Clinical features and prognostic model for extranasal NK/T-cell lymphoma
- (2012) Jae-Cheol Jo et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Complete remission after first-line radio-chemotherapy as predictor of survival in extranodal NK/T cell lymphoma
- (2012) Adrien Chauchet et al. Journal of Hematology & Oncology
- Radiotherapy Alone With Curative Intent in Patients With Stage I Extranodal Nasal-Type NK/T-Cell Lymphoma
- (2011) Ye-Xiong Li et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Phase II Study of SMILE Chemotherapy for Newly Diagnosed Stage IV, Relapsed, or Refractory Extranodal Natural Killer (NK)/T-Cell Lymphoma, Nasal Type: The NK-Cell Tumor Study Group Study
- (2011) Motoko Yamaguchi et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study
- (2010) A. Jaccard et al. BLOOD
- Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type
- (2009) R. Suzuki et al. ANNALS OF ONCOLOGY
- Immunohistochemical expression and clinical significance of P-glycoprotein in previously untreated extranodal NK/T-cell lymphoma, nasal type
- (2008) Biyun Wang et al. AMERICAN JOURNAL OF HEMATOLOGY
- Clinical heterogeneity of extranodal NK/T-cell lymphoma, nasal type: a national survey of the Korean Cancer Study Group
- (2008) T. M. Kim et al. ANNALS OF ONCOLOGY
- Autologous Hematopoietic Stem Cell Transplantation in Extranodal Natural Killer/T Cell Lymphoma: A Multinational, Multicenter, Matched Controlled Study
- (2008) Jeeyun Lee et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now